AKSY — Aksys Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $27.22m
- $2.67m
Annual income statement for Aksys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2001 December 31st | C2002 December 31st | C2003 December 31st | 2004 December 31st | 2005 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0.299 | 1.49 | 2.42 | 2.67 |
| Cost of Revenue | |||||
| Gross Profit | 0 | -2.47 | -6.2 | -8.25 | -12.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 17.8 | 16.3 | 24 | 29.5 | 35.7 |
| Operating Profit | -17.8 | -16 | -22.5 | -27.1 | -33.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -17.2 | -15.7 | -22.3 | -27.6 | -34.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.2 | -15.7 | -22.3 | -27.7 | -34.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -17.2 | -15.7 | -22.3 | -27.7 | -34.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -17.2 | -15.7 | -22.3 | -27.7 | -34.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.936 | -0.646 | -0.79 | -0.928 | -1.14 |
| Dividends per Share |